A Congenital Brucellosis Case of 34-day-old Girl

Dan Xu,Xuejing Li,Beilei Cheng,Yunlian Zhou,Mingming Zhou,Weizhong Gu,Zhimin Chen,Yingshuo Wang
DOI: https://doi.org/10.21203/rs.3.rs-152412/v1
2021-01-01
Abstract:Abstract Background: Brucellosis is the most common zoonotic infection over the world, caused by bacterial genus brucella. The disease is transmitted rarely via human-to-human transmission. Limited data support vertical transmission of human brucellosis. Herein, we reported a case of congenital brucellosis case with solid evidence of pathogen detected in mother’s placental specimen.Case presentation: A 34-day-old girl was admitted to department of pulmonology because of fever for eight days. Her mother had fatigue and arthralgia for 2 weeks, fever and membrane rupture 1 day before the baby was born. Three blood samples and one sample of cerebrospinal fluid showed positive with Brucella meliteusis. The diagnosis of brucellosis and Brucella meliteusis meningitis were established with hyperbilirubinemia and liver dysfunction. Treatment of rifampicin (6 weeks) and meropenem (2 weeks) was applied. However, the disease relapsed 3 weeks. A combination therapy of rifampicin and SMZ/TMP lasted for eight weeks. Brucella meliteusis DNA was detected by next-generation sequencing and bacterial identifying under microscope in mother’s placental specimen, which also proved chorioamnionitis. The baby was still in following-up.Conclusions: We reported a confirmed case of congenital brucellosis. This disease should be paid enough attention even in non epidemic areas. The treatment of brucellosis in infancy face the challenge of medicine choosing and disease relapse.
What problem does this paper attempt to address?